956 related articles for article (PubMed ID: 27005969)
1. Molecular typing of environmental Cryptococcus neoformans/C. gattii species complex isolates from Manaus, Amazonas, Brazil.
Alves GS; Freire AK; Bentes Ados S; Pinheiro JF; de Souza JV; Wanke B; Matsuura T; Jackisch-Matsuura AB
Mycoses; 2016 Aug; 59(8):509-15. PubMed ID: 27005969
[TBL] [Abstract][Full Text] [Related]
2. Genotypic diversity of environmental Cryptococcus neoformans isolates from Northern Portugal.
Ferreira AS; Sampaio A; Maduro AP; Silva I; Teles F; Martins Mda L; Inácio J
Mycoses; 2014 Feb; 57(2):98-104. PubMed ID: 23848429
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of clinical and environmental isolates from the Cryptococcus neoformans/C. Gattii species complexes of Maceió, Alagoas, Brazil.
de Holanda Fonseca DL; Silva DMWD; de Albuquerque Maranhão FC
Braz J Microbiol; 2024 Jun; 55(2):1369-1380. PubMed ID: 38619732
[TBL] [Abstract][Full Text] [Related]
4. Molecular typing and antifungal susceptibility of clinical and environmental Cryptococcus neoformans species complex isolates in Goiania, Brazil.
Souza LK; Souza Junior AH; Costa CR; Faganello J; Vainstein MH; Chagas AL; Souza AC; Silva MR
Mycoses; 2010 Jan; 53(1):62-7. PubMed ID: 19500261
[TBL] [Abstract][Full Text] [Related]
5. Molecular typing, in vitro susceptibility and virulence of Cryptococcus neoformans/Cryptococcus gattii species complex clinical isolates from south-eastern Brazil.
Grizante Barião PH; Tonani L; Cocio TA; Martinez R; Nascimento É; von Zeska Kress MR
Mycoses; 2020 Dec; 63(12):1341-1351. PubMed ID: 32869413
[TBL] [Abstract][Full Text] [Related]
6. First environmental isolations of Cryptococcus neoformans and Cryptococcus gattii in Tunisia and review of published studies on environmental isolations in Africa.
Mseddi F; Sellami A; Jarboui MA; Sellami H; Makni F; Ayadi A
Mycopathologia; 2011 May; 171(5):355-60. PubMed ID: 21197581
[TBL] [Abstract][Full Text] [Related]
7. Comparative typing analyses of clinical and environmental strains of the Cryptococcus neoformans/Cryptococcus gattii species complex from Ivory Coast.
Kassi FK; Bellet V; Drakulovski P; Krasteva D; Roger F; Valérie BA; Aboubakar T; Doumbia A; Kouakou GA; Delaporte E; Reynes J; Yavo W; Menan HIE; Bertout S
J Med Microbiol; 2018 Jan; 67(1):87-96. PubMed ID: 29214970
[TBL] [Abstract][Full Text] [Related]
8. Molecular types of Cryptococcus gattii/Cryptococcus neoformans species complex from clinical and environmental sources in Nairobi, Kenya.
Kangogo M; Bader O; Boga H; Wanyoike W; Folba C; Worasilchai N; Weig M; Groß U; Bii CC
Mycoses; 2015 Nov; 58(11):665-70. PubMed ID: 26404188
[TBL] [Abstract][Full Text] [Related]
9. Antifungal susceptibility of clinical and environmental Cryptococcus neoformans and Cryptococcus gattii isolates in Jabalpur, a city of Madhya Pradesh in Central India.
Gutch RS; Nawange SR; Singh SM; Yadu R; Tiwari A; Gumasta R; Kavishwar A
Braz J Microbiol; 2015; 46(4):1125-33. PubMed ID: 26691471
[TBL] [Abstract][Full Text] [Related]
10. Genotyping of Cryptococcus neoformans isolated from captive birds in Uberaba, Minas Gerais, Brazil.
Ferreira-Paim K; Andrade-Silva L; Mora DJ; Pedrosa AL; Rodrigues V; Silva-Vergara ML
Mycoses; 2011 Sep; 54(5):e294-300. PubMed ID: 20492533
[TBL] [Abstract][Full Text] [Related]
11. Molecular typing of clinical isolates of Cryptococcus neoformans/Cryptococcus gattii species complex from Northeast Mexico.
González GM; Casillas-Vega N; Garza-González E; Hernández-Bello R; Rivera G; Rodríguez JA; Bocanegra-Garcia V
Folia Microbiol (Praha); 2016 Jan; 61(1):51-6. PubMed ID: 26109075
[TBL] [Abstract][Full Text] [Related]
12. Molecular typing and in vitro antifungal susceptibility of Cryptococcus spp from patients in Midwest Brazil.
Favalessa OC; de Paula DA; Dutra V; Nakazato L; Tadano T; Lazera Mdos S; Wanke B; Trilles L; Walderez Szeszs M; Silva D; Hahn RC
J Infect Dev Ctries; 2014 Aug; 8(8):1037-43. PubMed ID: 25116671
[TBL] [Abstract][Full Text] [Related]
13. Environmental distribution of Cryptococcus neoformans and C. gattii around the Mediterranean basin.
Cogliati M; D'Amicis R; Zani A; Montagna MT; Caggiano G; De Giglio O; Balbino S; De Donno A; Serio F; Susever S; Ergin C; Velegraki A; Ellabib MS; Nardoni S; Macci C; Oliveri S; Trovato L; Dipineto L; Rickerts V; McCormick-Smith I; Akcaglar S; Tore O; Mlinaric-Missoni E; Bertout S; Mallié M; Martins Mda L; Vencà AC; Vieira ML; Sampaio AC; Pereira C; Criseo G; Romeo O; Ranque S; Al-Yasiri MH; Kaya M; Cerikcioglu N; Marchese A; Vezzulli L; Ilkit M; Desnos-Ollivier M; Pasquale V; Korem M; Polacheck I; Scopa A; Meyer W; Ferreira-Paim K; Hagen F; Theelen B; Boekhout T; Lockhart SR; Tintelnot K; Tortorano AM; Dromer F; Varma A; Kwon-Chung KJ; Inácio J; Alonso B; Colom MF
FEMS Yeast Res; 2016 Jun; 16(4):. PubMed ID: 27188887
[TBL] [Abstract][Full Text] [Related]
14. Microbiological characteristics of clinical isolates of Cryptococcus spp. in Bahia, Brazil: molecular types and antifungal susceptibilities.
Matos CS; de Souza Andrade A; Oliveira NS; Barros TF
Eur J Clin Microbiol Infect Dis; 2012 Jul; 31(7):1647-52. PubMed ID: 22278291
[TBL] [Abstract][Full Text] [Related]
15. First molecular typing of cryptococcemia-causing cryptococcus in central-west Brazil.
Tsujisaki RA; Paniago AM; Lima Júnior MS; Alencar Dde S; Spositto FL; Nunes Mde O; Trilles L; Chang MR
Mycopathologia; 2013 Oct; 176(3-4):267-72. PubMed ID: 23846587
[TBL] [Abstract][Full Text] [Related]
16. Molecular epidemiology and antifungal susceptibility profiles of clinical
Bandalizadeh Z; Shokohi T; Badali H; Abastabar M; Babamahmoudi F; Davoodi L; Mardani M; Javanian M; Cheraghmakani H; Sepidgar AA; Badiee P; Khodavaisy S; Afshari SAK; Ahmadikia K; Seyedmousavi S
J Med Microbiol; 2020 Jan; 69(1):72-81. PubMed ID: 31750814
[No Abstract] [Full Text] [Related]
17. Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.
Hagen F; Hare Jensen R; Meis JF; Arendrup MC
Mycoses; 2016 Sep; 59(9):576-84. PubMed ID: 27061834
[TBL] [Abstract][Full Text] [Related]
18. Molecular types of Cryptococcus neoformans and Cryptococcus gattii in Western Australia and correlation with antifungal susceptibility.
Lee GA; Arthur I; Merritt A; Leung M
Med Mycol; 2019 Nov; 57(8):1004-1010. PubMed ID: 30649538
[TBL] [Abstract][Full Text] [Related]
19. Cryptococcal meningitis in non-HIV patients in the State of Amazonas, Northern Brazil.
Pinheiro SB; Sousa ES; Cortez ACA; da Silva Rocha DF; Menescal LSF; Chagas VS; Gómez ASP; Cruz KS; Santos LO; Alves MJ; Matsuura ABJ; Wanke B; Trilles L; Frickmann H; de Souza JVB
Braz J Microbiol; 2021 Mar; 52(1):279-288. PubMed ID: 33025379
[TBL] [Abstract][Full Text] [Related]
20. In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India.
Chowdhary A; Randhawa HS; Sundar G; Kathuria S; Prakash A; Khan Z; Sun S; Xu J
J Med Microbiol; 2011 Jul; 60(Pt 7):961-967. PubMed ID: 21393452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]